In situ generation of EBNA1 CAR-T cells eradicates antigen specific auto-immune B cells for multiple sclerosis treatment
Study Overview This study investigates the potential of a novel therapeutic approach to treat multiple sclerosis (MS) by utilizing engineered […]
